Logo image of 27N0.DE

CANNOVUM CANNABIS AG (27N0.DE) Stock Fundamental Analysis

Europe - Frankfurt Stock Exchange - FRA:27N0 - DE000A37FUP2 - Common Stock

0.68 EUR
+0.03 (+4.62%)
Last: 1/19/2026, 7:00:00 PM
Fundamental Rating

1

Taking everything into account, 27N0 scores 1 out of 10 in our fundamental rating. 27N0 was compared to 0 industry peers in the Unkown industry. The financial health of 27N0 is average, but there are quite some concerns on its profitability. 27N0 does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year 27N0 has reported negative net income.
  • In the past 5 years 27N0 always reported negative net income.
  • 27N0 had a negative operating cash flow in each of the past 5 years.
27N0.DE Yearly Net Income VS EBIT VS OCF VS FCF27N0.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2023 2024 -1M -2M -3M

1.2 Ratios

Industry RankSector Rank
ROA -19.74%
ROE -28.97%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
27N0.DE Yearly ROA, ROE, ROIC27N0.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2023 2024 -500 -1K -1.5K -2K

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for 27N0 so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
27N0.DE Yearly Profit, Operating, Gross Margins27N0.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2023 2024 0 -2K -4K -6K -8K -10K

More info and screens

4

2. Health

2.1 Basic Checks

  • The number of shares outstanding for 27N0 has been increased compared to 1 year ago.
  • 27N0 has less shares outstanding than it did 5 years ago.
  • There is no outstanding debt for 27N0. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
27N0.DE Yearly Shares Outstanding27N0.DE Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2023 2024 500K 1M 1.5M 2M
27N0.DE Yearly Total Debt VS Total Assets27N0.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

  • There is no outstanding debt for 27N0. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACCN/A
27N0.DE Yearly LT Debt VS Equity VS FCF27N0.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2023 2024 2M 4M 6M 8M 10M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
27N0.DE Yearly Current Assets VS Current Liabilites27N0.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 500K 1M 1.5M

More info and screens

0

3. Growth

3.1 Past

  • 27N0 shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -96.40%.
  • 27N0 shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -67.86%.
EPS 1Y (TTM)-96.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%10.3%
Revenue 1Y (TTM)-67.86%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y89.29%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year100%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
27N0.DE Yearly Revenue VS Estimates27N0.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2024 2025 500K 1M 1.5M 2M
27N0.DE Yearly EPS VS Estimates27N0.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 -0.1 -0.2 -0.3 -0.4

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

  • 27N0 reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year 27N0 is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
27N0.DE Price Earnings VS Forward Price Earnings27N0.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
27N0.DE Per share data27N0.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 0.2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

  • 27N0 does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

CANNOVUM CANNABIS AG

FRA:27N0 (1/19/2026, 7:00:00 PM)

0.68

+0.03 (+4.62%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.57M
Revenue(TTM)1.80K
Net Income(TTM)-179.60K
Analysts82.86
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 872.67
P/FCF N/A
P/OCF N/A
P/B 2.53
P/tB 2.53
EV/EBITDA N/A
EPS(TTM)-0.07
EYN/A
EPS(NY)-0.03
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0
BVpS0.27
TBVpS0.27
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -19.74%
ROE -28.97%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-96.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%10.3%
EPS Next Y89.29%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-67.86%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year100%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-18.45%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year100%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

CANNOVUM CANNABIS AG / 27N0.DE FAQ

Can you provide the ChartMill fundamental rating for CANNOVUM CANNABIS AG?

ChartMill assigns a fundamental rating of 1 / 10 to 27N0.DE.


What is the valuation status of CANNOVUM CANNABIS AG (27N0.DE) stock?

ChartMill assigns a valuation rating of 0 / 10 to CANNOVUM CANNABIS AG (27N0.DE). This can be considered as Overvalued.


Can you provide the profitability details for CANNOVUM CANNABIS AG?

CANNOVUM CANNABIS AG (27N0.DE) has a profitability rating of 0 / 10.


How financially healthy is CANNOVUM CANNABIS AG?

The financial health rating of CANNOVUM CANNABIS AG (27N0.DE) is 4 / 10.